CAL-130 is primarily used in research settings, particularly in the study of cellular signaling pathways. It is known to act as an inhibitor of the PI3K/AKT/mTOR pathway, which plays a critical role in cell growth, proliferation, and survival. By inhibiting this pathway, CAL-130 helps researchers investigate the mechanisms of cancer development and progression, as this pathway is often dysregulated in various types of cancer. Additionally, it is used to explore potential therapeutic strategies for targeting cancers that are dependent on PI3K signaling. Its application extends to understanding the role of PI3K in other diseases, such as metabolic disorders and immune system dysfunctions, making it a valuable tool in biomedical research.